Loading…

Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: A prospective population-based study over the last year of life

Abstract Objective The aim of this study was to describe the trajectory of physical symptoms, coping styles and quality of life (QoL) and the relationship between coping and QoL over the last year of life in women with recurrent ovarian cancer. Methods The patient cohort were women recruited to the...

Full description

Saved in:
Bibliographic Details
Published in:Gynecologic oncology 2013-07, Vol.130 (1), p.162-168
Main Authors: Price, M.A, Bell, M.L, Sommeijer, D.W, Friedlander, M, Stockler, M.R, deFazio, A, Webb, P.M, Butow, P.N
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c459t-1c1525ce7d9721778b72982549a13f077bbe06babeddc9917cf4b61dfff5195b3
cites cdi_FETCH-LOGICAL-c459t-1c1525ce7d9721778b72982549a13f077bbe06babeddc9917cf4b61dfff5195b3
container_end_page 168
container_issue 1
container_start_page 162
container_title Gynecologic oncology
container_volume 130
creator Price, M.A
Bell, M.L
Sommeijer, D.W
Friedlander, M
Stockler, M.R
deFazio, A
Webb, P.M
Butow, P.N
description Abstract Objective The aim of this study was to describe the trajectory of physical symptoms, coping styles and quality of life (QoL) and the relationship between coping and QoL over the last year of life in women with recurrent ovarian cancer. Methods The patient cohort were women recruited to the Australian Ovarian Cancer Study who subsequently experienced recurrent, invasive ovarian cancer and completed at least one psychosocial assessment (optimism, minimisation, hopelessness/helplessness, QoL) during the last year of life ( n = 217). Results QoL declined sharply from six months before death. Lack of energy was the most prevalent symptom over three measurement periods (67–92%) and also the most severe. Anorexia (36–55%), abdominal swelling (33–58%), nausea (26–47%) and pain (26–43%) all increased in prevalence and severity towards the end of life. Higher optimism ( p = 0.009), higher minimisation ( p = 0.003) and lower helplessness/hopelessness ( p = 0.03) at baseline were significant predictors of subsequent higher QoL. Conclusions Progressive deterioration in quality of life may be an indicator of death within about six months and therefore should be an important consideration in decisions about subsequent treatment. Coping styles which independently predicted subsequent changes in QoL could potentially be targeted by interventions to minimise worsening QoL.
doi_str_mv 10.1016/j.ygyno.2013.03.031
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1369233766</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0090825813002187</els_id><sourcerecordid>1369233766</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-1c1525ce7d9721778b72982549a13f077bbe06babeddc9917cf4b61dfff5195b3</originalsourceid><addsrcrecordid>eNqFUk2LFDEUDKK44-ovECRHD_aYj0mnIygsi1-woKCeQzr9ejdjJulN0gP9M_zHpp1dD16EB7lU1UtVPYSeU7KlhLav99vleglxywjlW7IOfYA2lCjRtJ1QD9GGEEWajonuDD3JeU8I4YSyx-iMcSE7wbsN-vX1ZsnOGo_zcphKPORX2MbJhWucy-IhYxMGfDsb78qC44i9GwG7gBPYOSUIBcejSc4EbE2wkN7gCzylmCewxR0BT3GavSkuhqY3GYYqOw9V6QgJlxvA3uSCFzDpXvwpejQan-HZ3XuOfnx4__3yU3P15ePny4urxu6EKg21VDBhQQ5KMipl10umqtedMpSPRMq-B9L2podhsEpRacdd39JhHEdBlej5OXp50q2_vZ0hF31w2YL3JkCcs6a8VYxz2bYVyk9QW43lBKOekjuYtGhK9NqF3us_Xei1C03WoZX14m7B3B9g-Mu5D78C3p4AUG0eHSSdrYMa4uBqukUP0f1nwbt_-Na7sJb5ExbI-zinUBPUVGemif62nsN6DZQTwmgn-W9YjrO3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1369233766</pqid></control><display><type>article</type><title>Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: A prospective population-based study over the last year of life</title><source>Elsevier</source><creator>Price, M.A ; Bell, M.L ; Sommeijer, D.W ; Friedlander, M ; Stockler, M.R ; deFazio, A ; Webb, P.M ; Butow, P.N</creator><creatorcontrib>Price, M.A ; Bell, M.L ; Sommeijer, D.W ; Friedlander, M ; Stockler, M.R ; deFazio, A ; Webb, P.M ; Butow, P.N ; The Australian Ovarian Cancer Study Group ; The Australian Ovarian Cancer Study Quality of Life Study Investigators ; Australian Ovarian Cancer Study Group ; Australian Ovarian Cancer Study Quality of Life Study Investigators</creatorcontrib><description>Abstract Objective The aim of this study was to describe the trajectory of physical symptoms, coping styles and quality of life (QoL) and the relationship between coping and QoL over the last year of life in women with recurrent ovarian cancer. Methods The patient cohort were women recruited to the Australian Ovarian Cancer Study who subsequently experienced recurrent, invasive ovarian cancer and completed at least one psychosocial assessment (optimism, minimisation, hopelessness/helplessness, QoL) during the last year of life ( n = 217). Results QoL declined sharply from six months before death. Lack of energy was the most prevalent symptom over three measurement periods (67–92%) and also the most severe. Anorexia (36–55%), abdominal swelling (33–58%), nausea (26–47%) and pain (26–43%) all increased in prevalence and severity towards the end of life. Higher optimism ( p = 0.009), higher minimisation ( p = 0.003) and lower helplessness/hopelessness ( p = 0.03) at baseline were significant predictors of subsequent higher QoL. Conclusions Progressive deterioration in quality of life may be an indicator of death within about six months and therefore should be an important consideration in decisions about subsequent treatment. Coping styles which independently predicted subsequent changes in QoL could potentially be targeted by interventions to minimise worsening QoL.</description><identifier>ISSN: 0090-8258</identifier><identifier>EISSN: 1095-6859</identifier><identifier>DOI: 10.1016/j.ygyno.2013.03.031</identifier><identifier>PMID: 23578538</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adaptation, Psychological ; Coping ; End of life ; Female ; Hematology, Oncology and Palliative Medicine ; Humans ; Middle Aged ; Neoplasm Recurrence, Local - physiopathology ; Neoplasm Recurrence, Local - psychology ; Neoplasm Recurrence, Local - therapy ; Obstetrics and Gynecology ; Ovarian cancer ; Ovarian Neoplasms - physiopathology ; Ovarian Neoplasms - psychology ; Ovarian Neoplasms - therapy ; Prospective Studies ; Psychosocial ; Quality of Life ; Symptoms</subject><ispartof>Gynecologic oncology, 2013-07, Vol.130 (1), p.162-168</ispartof><rights>2013</rights><rights>Crown Copyright © 2013. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-1c1525ce7d9721778b72982549a13f077bbe06babeddc9917cf4b61dfff5195b3</citedby><cites>FETCH-LOGICAL-c459t-1c1525ce7d9721778b72982549a13f077bbe06babeddc9917cf4b61dfff5195b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23578538$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Price, M.A</creatorcontrib><creatorcontrib>Bell, M.L</creatorcontrib><creatorcontrib>Sommeijer, D.W</creatorcontrib><creatorcontrib>Friedlander, M</creatorcontrib><creatorcontrib>Stockler, M.R</creatorcontrib><creatorcontrib>deFazio, A</creatorcontrib><creatorcontrib>Webb, P.M</creatorcontrib><creatorcontrib>Butow, P.N</creatorcontrib><creatorcontrib>The Australian Ovarian Cancer Study Group</creatorcontrib><creatorcontrib>The Australian Ovarian Cancer Study Quality of Life Study Investigators</creatorcontrib><creatorcontrib>Australian Ovarian Cancer Study Group</creatorcontrib><creatorcontrib>Australian Ovarian Cancer Study Quality of Life Study Investigators</creatorcontrib><title>Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: A prospective population-based study over the last year of life</title><title>Gynecologic oncology</title><addtitle>Gynecol Oncol</addtitle><description>Abstract Objective The aim of this study was to describe the trajectory of physical symptoms, coping styles and quality of life (QoL) and the relationship between coping and QoL over the last year of life in women with recurrent ovarian cancer. Methods The patient cohort were women recruited to the Australian Ovarian Cancer Study who subsequently experienced recurrent, invasive ovarian cancer and completed at least one psychosocial assessment (optimism, minimisation, hopelessness/helplessness, QoL) during the last year of life ( n = 217). Results QoL declined sharply from six months before death. Lack of energy was the most prevalent symptom over three measurement periods (67–92%) and also the most severe. Anorexia (36–55%), abdominal swelling (33–58%), nausea (26–47%) and pain (26–43%) all increased in prevalence and severity towards the end of life. Higher optimism ( p = 0.009), higher minimisation ( p = 0.003) and lower helplessness/hopelessness ( p = 0.03) at baseline were significant predictors of subsequent higher QoL. Conclusions Progressive deterioration in quality of life may be an indicator of death within about six months and therefore should be an important consideration in decisions about subsequent treatment. Coping styles which independently predicted subsequent changes in QoL could potentially be targeted by interventions to minimise worsening QoL.</description><subject>Adaptation, Psychological</subject><subject>Coping</subject><subject>End of life</subject><subject>Female</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local - physiopathology</subject><subject>Neoplasm Recurrence, Local - psychology</subject><subject>Neoplasm Recurrence, Local - therapy</subject><subject>Obstetrics and Gynecology</subject><subject>Ovarian cancer</subject><subject>Ovarian Neoplasms - physiopathology</subject><subject>Ovarian Neoplasms - psychology</subject><subject>Ovarian Neoplasms - therapy</subject><subject>Prospective Studies</subject><subject>Psychosocial</subject><subject>Quality of Life</subject><subject>Symptoms</subject><issn>0090-8258</issn><issn>1095-6859</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqFUk2LFDEUDKK44-ovECRHD_aYj0mnIygsi1-woKCeQzr9ejdjJulN0gP9M_zHpp1dD16EB7lU1UtVPYSeU7KlhLav99vleglxywjlW7IOfYA2lCjRtJ1QD9GGEEWajonuDD3JeU8I4YSyx-iMcSE7wbsN-vX1ZsnOGo_zcphKPORX2MbJhWucy-IhYxMGfDsb78qC44i9GwG7gBPYOSUIBcejSc4EbE2wkN7gCzylmCewxR0BT3GavSkuhqY3GYYqOw9V6QgJlxvA3uSCFzDpXvwpejQan-HZ3XuOfnx4__3yU3P15ePny4urxu6EKg21VDBhQQ5KMipl10umqtedMpSPRMq-B9L2podhsEpRacdd39JhHEdBlej5OXp50q2_vZ0hF31w2YL3JkCcs6a8VYxz2bYVyk9QW43lBKOekjuYtGhK9NqF3us_Xei1C03WoZX14m7B3B9g-Mu5D78C3p4AUG0eHSSdrYMa4uBqukUP0f1nwbt_-Na7sJb5ExbI-zinUBPUVGemif62nsN6DZQTwmgn-W9YjrO3</recordid><startdate>20130701</startdate><enddate>20130701</enddate><creator>Price, M.A</creator><creator>Bell, M.L</creator><creator>Sommeijer, D.W</creator><creator>Friedlander, M</creator><creator>Stockler, M.R</creator><creator>deFazio, A</creator><creator>Webb, P.M</creator><creator>Butow, P.N</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130701</creationdate><title>Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: A prospective population-based study over the last year of life</title><author>Price, M.A ; Bell, M.L ; Sommeijer, D.W ; Friedlander, M ; Stockler, M.R ; deFazio, A ; Webb, P.M ; Butow, P.N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-1c1525ce7d9721778b72982549a13f077bbe06babeddc9917cf4b61dfff5195b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adaptation, Psychological</topic><topic>Coping</topic><topic>End of life</topic><topic>Female</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local - physiopathology</topic><topic>Neoplasm Recurrence, Local - psychology</topic><topic>Neoplasm Recurrence, Local - therapy</topic><topic>Obstetrics and Gynecology</topic><topic>Ovarian cancer</topic><topic>Ovarian Neoplasms - physiopathology</topic><topic>Ovarian Neoplasms - psychology</topic><topic>Ovarian Neoplasms - therapy</topic><topic>Prospective Studies</topic><topic>Psychosocial</topic><topic>Quality of Life</topic><topic>Symptoms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Price, M.A</creatorcontrib><creatorcontrib>Bell, M.L</creatorcontrib><creatorcontrib>Sommeijer, D.W</creatorcontrib><creatorcontrib>Friedlander, M</creatorcontrib><creatorcontrib>Stockler, M.R</creatorcontrib><creatorcontrib>deFazio, A</creatorcontrib><creatorcontrib>Webb, P.M</creatorcontrib><creatorcontrib>Butow, P.N</creatorcontrib><creatorcontrib>The Australian Ovarian Cancer Study Group</creatorcontrib><creatorcontrib>The Australian Ovarian Cancer Study Quality of Life Study Investigators</creatorcontrib><creatorcontrib>Australian Ovarian Cancer Study Group</creatorcontrib><creatorcontrib>Australian Ovarian Cancer Study Quality of Life Study Investigators</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gynecologic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Price, M.A</au><au>Bell, M.L</au><au>Sommeijer, D.W</au><au>Friedlander, M</au><au>Stockler, M.R</au><au>deFazio, A</au><au>Webb, P.M</au><au>Butow, P.N</au><aucorp>The Australian Ovarian Cancer Study Group</aucorp><aucorp>The Australian Ovarian Cancer Study Quality of Life Study Investigators</aucorp><aucorp>Australian Ovarian Cancer Study Group</aucorp><aucorp>Australian Ovarian Cancer Study Quality of Life Study Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: A prospective population-based study over the last year of life</atitle><jtitle>Gynecologic oncology</jtitle><addtitle>Gynecol Oncol</addtitle><date>2013-07-01</date><risdate>2013</risdate><volume>130</volume><issue>1</issue><spage>162</spage><epage>168</epage><pages>162-168</pages><issn>0090-8258</issn><eissn>1095-6859</eissn><abstract>Abstract Objective The aim of this study was to describe the trajectory of physical symptoms, coping styles and quality of life (QoL) and the relationship between coping and QoL over the last year of life in women with recurrent ovarian cancer. Methods The patient cohort were women recruited to the Australian Ovarian Cancer Study who subsequently experienced recurrent, invasive ovarian cancer and completed at least one psychosocial assessment (optimism, minimisation, hopelessness/helplessness, QoL) during the last year of life ( n = 217). Results QoL declined sharply from six months before death. Lack of energy was the most prevalent symptom over three measurement periods (67–92%) and also the most severe. Anorexia (36–55%), abdominal swelling (33–58%), nausea (26–47%) and pain (26–43%) all increased in prevalence and severity towards the end of life. Higher optimism ( p = 0.009), higher minimisation ( p = 0.003) and lower helplessness/hopelessness ( p = 0.03) at baseline were significant predictors of subsequent higher QoL. Conclusions Progressive deterioration in quality of life may be an indicator of death within about six months and therefore should be an important consideration in decisions about subsequent treatment. Coping styles which independently predicted subsequent changes in QoL could potentially be targeted by interventions to minimise worsening QoL.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>23578538</pmid><doi>10.1016/j.ygyno.2013.03.031</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0090-8258
ispartof Gynecologic oncology, 2013-07, Vol.130 (1), p.162-168
issn 0090-8258
1095-6859
language eng
recordid cdi_proquest_miscellaneous_1369233766
source Elsevier
subjects Adaptation, Psychological
Coping
End of life
Female
Hematology, Oncology and Palliative Medicine
Humans
Middle Aged
Neoplasm Recurrence, Local - physiopathology
Neoplasm Recurrence, Local - psychology
Neoplasm Recurrence, Local - therapy
Obstetrics and Gynecology
Ovarian cancer
Ovarian Neoplasms - physiopathology
Ovarian Neoplasms - psychology
Ovarian Neoplasms - therapy
Prospective Studies
Psychosocial
Quality of Life
Symptoms
title Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: A prospective population-based study over the last year of life
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T14%3A34%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Physical%20symptoms,%20coping%20styles%20and%20quality%20of%20life%20in%20recurrent%20ovarian%20cancer:%20A%20prospective%20population-based%20study%20over%20the%20last%20year%20of%20life&rft.jtitle=Gynecologic%20oncology&rft.au=Price,%20M.A&rft.aucorp=The%20Australian%20Ovarian%20Cancer%20Study%20Group&rft.date=2013-07-01&rft.volume=130&rft.issue=1&rft.spage=162&rft.epage=168&rft.pages=162-168&rft.issn=0090-8258&rft.eissn=1095-6859&rft_id=info:doi/10.1016/j.ygyno.2013.03.031&rft_dat=%3Cproquest_cross%3E1369233766%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c459t-1c1525ce7d9721778b72982549a13f077bbe06babeddc9917cf4b61dfff5195b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1369233766&rft_id=info:pmid/23578538&rfr_iscdi=true